Work

A phase I study of estramustine, weekly docetaxel and carboplatin (EDC) chemotherapy in patients with hormone refractory prostate cancer (HRPC)

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.4656

Authors: W. K. Oh, E. Hagmann, J. Manola, D. J. George, T. D. Gilligan, M. R. Smith, D. S. Kaufman, P. W. Kantoff

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute, Duke Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2284685264

Cites:

Cited by:

Related to: 10